AKBA Akebia Therapeutics, Inc.

P/E --

Forward P/E 28.74

Price/Sales 0.74

Beta 0.18

Div Yield --

Market Cap --

Company Analysis

Latest News

October 23, 2026

Akebia Therapeutics Receives Nasdaq Notice for Non-Compliance with Minimum Bid Price Rule

Akebia Therapeutics, Inc. (AKBA) announced it received a deficiency notice from the Nasdaq Stock Market on October 21, 2026. The notice was issued because the...